Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies
Cardiology Clinics · 2023
DOI: 10.1016/j.ccl.2023.06.008 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cardiology Clinics, 2023. Verfasst von Michael J Pienta und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: mpienta@med.umich.edu. Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Failure, Stroke Volume, Cardiac Catheterization. Die Arbeit nennt 42 Literaturangaben.
Abstract (Originalsprache)
Transcatheter mitral valve repair should be considered for patients with severe secondary mitral regurgitation with symptomatic heart failure with reduced ejection fraction for symptom improvement and survival benefit. Patients with a higher severity of secondary mitral regurgitation relative to the degree of left ventricular dilation are more likely to benefit from transcatheter mitral valve repair. A multidisciplinary Heart Team should participate in patient selection for transcatheter mitral valve therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiac Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA. Electronic address: mpienta@med.umich.edu.
- Department of Cardiac Surgery, Michigan Medicine, University of Michigan, Ann Arbor, MI, USA.
Zitieren
APA
Pienta, M. J., & Romano, M. A. (2023). Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies. Cardiology Clinics. https://doi.org/10.1016/j.ccl.2023.06.008
Vancouver
Pienta MJ, Romano MA. Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies. Cardiology Clinics. 2023. doi:10.1016/j.ccl.2023.06.008
BibTeX
@article{Pienta2023,
author = {Pienta, Michael J and Romano, Matthew A},
title = {Secondary Mitral Regurgitation and Transcatheter Mitral Valve Therapies},
journal = {Cardiology Clinics},
year = {2023},
doi = {10.1016/j.ccl.2023.06.008}
}
EUVIMED